Home NDC 59011-523 Symproic
Product NDC 59011-523
11-digit product format 590110523
Labeler code 59011
Product ID 59011-523_340af158-2ff5-30f1-26e0-b60882e7c144
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name naldemedine
Dosage form TABLET
Route ORAL
Labeler Purdue Pharma LP
Application NDA208854
Marketing category NDA
Marketing start 2017-03-23
Marketing end 2020-12-31
Substance NALDEMEDINE TOSYLATE
Active strength 0 mg/1
Pharmacologic classes Opioid Antagonist [EPC],Opioid Antagonists [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208854-001 SYMPROIC NALDEMEDINE TOSYLATE EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 N208854-001 12350377 2033-05-13 Drug product 2025-07-11
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208854-001 SYMPROIC EQ 0.2MG BASE TABLET / ORAL RLD, RS 2017-03-23 f41ea6bd6efb…
Observed Orange Book patent history# Patent history page 1 of 5 · 170 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208854-001 12350377 2033-05-13 Drug product 2025-07-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208854-001 12350377 2033-05-13 Drug product 2025-07-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208854-001 12350377 2033-05-13 Drug product 2025-07-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208854-001 12350377 2033-05-13 Drug product 2025-07-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208854-001 RE46365 2031-02-24 Drug substance, Drug product 2017-05-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208854-001 12350377 2033-05-13 Drug product 2025-07-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208854-001 RE46365 2028-01-11 Drug substance, Drug product 2017-05-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208854-001 RE46365 2028-01-11 Drug substance, Drug product 2017-05-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208854-001 RE46365 2028-01-11 Drug substance, Drug product 2017-05-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208854-001 10952968 2033-05-13 Drug substance, Drug product 2021-04-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208854-001 RE46375 2026-10-05 U-1185 Drug substance, Drug product 2017-05-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208854-001 RE46365 2028-01-11 Drug substance, Drug product 2017-05-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208854-001 9108975 2031-11-11 Drug substance, Drug product 2017-03-31 2680178bc6a6…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join SYMPROIC NALDEMEDINE BioDelivery Sciences International Inc b1a1256c-a1eb-4abe-ab1e-30e4711afd16 2025-07-25 Warnings, Adverse reactions Exact identifier application applno (NDA): 208854 application number: NDA208854